{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:25:27Z","timestamp":1778808327971,"version":"3.51.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertonic saline solution is critical for managing symptomatic hyponatremia and increased intracranial pressure (IICP). Though administered via central venous catheters (CVCs) traditionally, peripheral administration is a viable alternative, reducing delays and CVC-associated risks. This review evaluates the safety of peripheral hypertonic saline, focusing on infusion-related adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of MEDLINE, Embase, and Cochrane Library (up to December 2024) identified studies on peripheral hypertonic saline in adults. Studies reporting phlebitis, infiltration, extravasation, and thrombosis were included. Two reviewers independently screened studies and extracted data. Quality was assessed using the Newcastle-Ottawa Scale and Risk of Bias 2 tool. The review is registered on PROSPERO (CRD42024612330).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen studies involving 2,354 patients were included, comprising one randomized controlled trial and 12 cohort studies. Quality assessment showed a low risk of bias across all included studies. The pooled incidence of phlebitis was 2.3% (95% CI: 1.2%\u22124.1%), while infiltration and extravasation occurred at a rate of 2.1% (95% CI: 1.1%\u22123.9%). Thrombosis was rare, with an incidence of 0.8% (95% CI: 0.3%\u22121.7%). Most complications were mild and resolved conservatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Peripheral hypertonic saline is a safe alternative to CVC placement, particularly in urgent situations where rapid intervention is required. Low complication rates support its broader use in clinical practice, enabling timely treatment while minimizing the risks associated with central access. These findings support consideration for updates to clinical guidelines, advocating for peripheral hypertonic saline as a first-line option in appropriate scenarios to enhance patient outcomes and streamline care delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , identifier: CRD42024612330.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1704530","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:32:10Z","timestamp":1762842730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety of peripheral intravenous administration of hypertonic saline: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Sih-Shiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Wei","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Tai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu-Yang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Chung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Pei-Chuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1530\/EJE-20-1207","article-title":"Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study","volume":"184","author":"Chifu","year":"2021","journal-title":"Eur J Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s40001-022-00897-4","article-title":"Hypertonic saline for traumatic brain injury: a systematic review and meta-analysis","volume":"27","author":"Gharizadeh","year":"2022","journal-title":"Eur J Med Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/j.ajkd.2021.07.020","article-title":"Hypertonic saline for hyponatremia: meeting goals and avoiding harm","volume":"79","author":"Rondon-Berrios","year":"2022","journal-title":"Am J Kidney Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajem.2022.07.023","article-title":"Hyponatremia in the emergency department","volume":"60","author":"Lindner","year":"2022","journal-title":"Am J Emerg Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"20220894","DOI":"10.1259\/bjr.20220894","article-title":"Central venous catheters: which, when and how","volume":"96","author":"Kehagias","year":"2023","journal-title":"Br J Radiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/JNN.0000000000000286","article-title":"Complication rates of 3% hypertonic saline infusion through peripheral intravenous access","volume":"49","author":"Perez","year":"2017","journal-title":"J Neurosci Nurs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0885066617702590","article-title":"Incidence of adverse events during peripheral administration of sodium chloride 3","volume":"33","author":"Dillon","year":"2018","journal-title":"J Intensive Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.amjms.2023.04.025","article-title":"The safety of intravenous peripheral administration of 3% hypertonic saline: a systematic review and meta-analysis","volume":"366","author":"Madieh","year":"2023","journal-title":"Am J Med Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3978\/j.issn.2305-5839.2015.02.11","article-title":"Pneumothorax as a complication of central venous catheter insertion","volume":"3","author":"Tsotsolis","year":"2015","journal-title":"Ann Transl Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1056\/NEJMoa1500964","article-title":"Intravascular complications of central venous catheterization by insertion site","volume":"373","author":"Parienti","year":"2015","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/annonc\/mdm350","article-title":"Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies","volume":"19","author":"Boersma","year":"2008","journal-title":"Ann Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2046-4053-1-2","article-title":"The nuts and bolts of PROSPERO: an international prospective register of systematic reviews","volume":"1","author":"Booth","year":"2012","journal-title":"Syst Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4037\/ajcc2017439","article-title":"Safety of continuous peripheral infusion of 3% sodium chloride solution in neurocritical care patients","volume":"26","author":"Jones","year":"2016","journal-title":"Am J Crit Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2146\/ajhp161028","article-title":"Caulfield AF. Association between continuous peripheral iv infusion of 3% sodium chloride injection and phlebitis in adults","volume":"75","author":"Meng","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jemermed.2018.12.046","article-title":"Safety of peripheral line administration of 3% hypertonic saline and mannitol in the emergency department","volume":"56","author":"Mesghali","year":"2019","journal-title":"J Emerg Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamainternmed.2020.5519","article-title":"Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial","volume":"181","author":"Baek","year":"2021","journal-title":"JAMA Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/wvn.12501","article-title":"Administration of 3% sodium chloride through peripheral intravenous access: development and implementation of a protocol for clinical practice","volume":"18","author":"Jannotta","year":"2021","journal-title":"Worldviews Evid Based Nurs."},{"key":"B21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s12028-021-01248-7","article-title":"Rajajee V. Safety and efficacy of 234% sodium chloride administered via peripheral venous access for the treatment of cerebral herniation and intracranial pressure elevation","volume":"35","author":"Faiver","year":"2021","journal-title":"Neurocrit Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajem.2023.04.007","article-title":"Safety of peripheral 3% hypertonic saline bolus administration for neurologic emergency","volume":"69","author":"Brown","year":"2023","journal-title":"Am J Emerg Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajem.2022.10.051","article-title":"Safety of peripherally administered 3% hypertonic saline","volume":"63","author":"Deveau RF","year":"2023","journal-title":"Am J Emerg Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.56397\/JIMR\/2023.02.06","article-title":"Safety of administration of hypertonic sodium chloride solution through peripheral IV in neuroscience intensive care unit, KAMC, Makkah","volume":"2","author":"Shafi","year":"2023","journal-title":"J Innov Med Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s44231-024-00062-x","article-title":"Assessment of 2% vs 3% peripheral hypertonic sodium chloride administration and its impact on safe and timely treatment","volume":"4","author":"Dumont","year":"2024","journal-title":"Intensive Care Research."},{"key":"B26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12028-024-01941-3","article-title":"Safety and effect on intracranial pressure of 3% hypertonic saline bolus via peripheral intravenous catheter for neurological emergencies","volume":"41","author":"Khasiyev","year":"2024","journal-title":"Neurocrit Care."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/NAN.0000000000000396","article-title":"Infusion therapy standards of practice, 8th edition","volume":"44","author":"Gorski","year":"2021","journal-title":"J Infus Nurs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMra011883","article-title":"Preventing complications of central venous catheterization","volume":"348","author":"McGee","year":"2003","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4037\/ccn2021400","article-title":"Safety of peripheral administration of 3% hypertonic saline in critically ill patients: a literature review","volume":"41","author":"Alenazi","year":"2021","journal-title":"Crit Care Nurse."},{"key":"B30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jamainternmed.2024.5981","article-title":"Correction rates and clinical outcomes in hospitalized adults with severe hyponatremia: a systematic review and meta-analysis","volume":"185","author":"Ayus","year":"2025","journal-title":"JAMA Intern Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11910-024-01392-5","article-title":"Managing intracranial pressure crisis","volume":"25","author":"Viarasilpa","year":"2024","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/PCC.0000000000002924","article-title":"Saving brain and vein: administering hypertonic saline through a peripheral IV catheter","volume":"23","author":"Herrmann","year":"2022","journal-title":"Pediatr Crit Care Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1704530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:32:31Z","timestamp":1762842751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1704530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":32,"alternative-id":["10.3389\/fmed.2025.1704530"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1704530","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"article-number":"1704530"}}